HIV treatment as prevention: Natural experiments highlight limits of antiretroviral treatment as HIV prevention

PLoS Medicine

Volumn 9, Issue 7, 2012, Pages

  Wilson, David P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AUSTRALIA; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; FRANCE; HEALTH PROGRAM; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION RISK; PREVALENCE; REVIEW; SEXUAL BEHAVIOR; UNITED STATES; VIRUS LOAD; VIRUS TRANSMISSION; CANADA; DISEASE TRANSMISSION;

ANTI-HIV AGENTS; AUSTRALIA; BRITISH COLUMBIA; FRANCE; HIV INFECTIONS; HUMANS; SAN FRANCISCO;

EID: 84864479588     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001231     Document Type: Review

References (70)

1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
2. Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, et al. (2006) The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368: 531-536.
3. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376: 532-539.
4. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, et al. (2010) Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 5: e11068 doi:10.1371/journal.pone.0011068.
5. Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, et al. (2011) Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 56: 263-269.
6. Anglemyer A, Rutherford GW, Baggaley RC, Egger M, Siegfried N, (2011) Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev 2011: CD009153.
7. Attia S, Egger M, Muller M, Zwahlen M, Low N, (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23: 1397-1404.
8. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 342: 921-929.
9. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
10. Holtgrave DR, (2010) Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model. Public Health Rep 125: 372-376.
11. Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, et al. (2012) HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 9: e1001245 doi:10.1371/journal.pmed.1001245.
12. Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, et al. (2011) Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res 9: 446-469.
13. British Columbia Centre for Excellence in HIV/AIDS (2011) Therapeutic guidelines: antiretroviral treatment (ARV) of adult HIV infection-as of January 2011. Available: http://www.cfenet.ubc.ca/sites/default/files/uploads/BCCfE%20Adult%20Therapeutic%20Guidelines_Jan2011.pdf. Accessed 7 December 2011.
14. Smith MK, Powers KA, Muessig KE, Miller WC, Cohen MS, (2012) HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med 9: e1001260 doi:10.1371/journal.pmed.1001260.
15. Kerr T, Small W, Buchner C, Zhang R, Li K, et al. (2010) Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health 100: 1449-1453.
16. San Francisco Department of Public Health HIV/AIDS Statistics and Epidemiology Section (2009) HIV/AIDS epidemiology annual report 2008 San Francisco San Francisco Department of Public Health.
17. Scheer S, Kellogg T, Klausner JD, Schwarcz S, Colfax G, et al. (2008) HIV is hyperendemic among men who have sex with men in San Francisco. Sex Transm Infect 84: 493-498.
18. San Francisco Department of Public Health HIV/AIDS Statistics, Epidemiology, and Intervention Research Section (2005) HIV/AIDS epidemiology annual report: 2005. Available: http://sfhiv.org/files/data_reports/hiv_aids_annual_rpt/HIVAIDAnnlRpt2005.pdf. Accessed 10 May 2012.
19. Bourdillon F, Cadore B, Dozon J-P, Gaudin P, Kapusta-Palmer C, et al. (2009) April 9 Statement followed by recommendations on the appropriateness of treatment as an innovative tool for fighting the epidemic of HIV infections Paris Conseil National du SIDA.
20. Joint United Nations Programme on HIV/AIDS (2010) Epidemiological factsheet: France Geneva Joint United Nations Programme on HIV/AIDS.
21. Haute Autorité de Santé (2009) HIV infection screening in France: screening strategies Saint-Denis La Plaine (France) Haute Autorité de Santé.
22. Wilson DP, Hoare A, Regan DG, Wand H, Law M, (2008) Mathematical models to investigate recent trends in HIV notifications among men who have sex with men in Australia Sydney National Centre in HIV Epidemiology and Clinical Research.
23. Jin F, Prestage GP, McDonald A, Ramacciotti T, Imrie JC, et al. (2008) Trend in HIV incidence in a cohort of homosexual men in Sydney: data from the Health in Men Study. Sex Health 5: 109-112.
24. Glynn MK, Rhodes P, (2005) Estimated HIV prevalence in the United States at the end of 2003 [abstract]. National HIV Prevention Conference; Atlanta, Georgia; 12-15 June 2005.
25. Branson B, (2007) Current HIV epidemiology and revised recommendations for HIV testing in health-care settings. J Med Virol 79 (Suppl 1): S6-S10.
26. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55: 1-17.
27. Stekler JD, Golden MR, (2009) Learning from the missed opportunities for HIV testing. Sex Transm Infect 85: 2-3.
28. Dodds JP, Johnson AM, Parry JV, Mercey DE, (2007) A tale of three cities: persisting high HIV prevalence, risk behaviour and undiagnosed infection in community samples of men who have sex with men. Sex Transm Infect 83: 392-396.
29. Latthaphasavang V, Bouldouyre MA, Rachline A, Ponscarme D, Rozenbaum W, et al. (2012) Antiretroviral therapy initiation in france: adherence to national guidelines and outcome. J Int Assoc Physicians AIDS Care (Chic) 11: 40-46.
30. Le Vu S, Le Strat Y, Barin F, illonel J, Cazein F, et al. PSurveillance de la syphilis en France, 2000-2006: recrudescence des diagnostics en 2006 (2010) Population-based HIV-1 incidence in France, 2003-08: a modelling analysis. Lancet Infect Dis 10: 682-687.
31. Velter A, Bouyssou-Michel A, de Busscher PO, Jauff ret-Roustide M, Semaille C, (2007) Enquête presse gay 2004 Saint-Maurice Institut de Veille Sanitaire.
32. Bouyssou Michel A, Gallay A, Janier M, Dupin N, Halioua B, et al. (2008) Surveillance de la syphilis en France, 2000-2006: recrudescence des diagnostics en 2006. Bull Epidemiol Hebdo 5-6: 39-42.
33. The Kirby Institute (2011) HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2011 Sydney University of New South Wales.
34. Fogarty A, Mao L, Zablotska I, Salter M, Prestage G, et al. (2006) The Health in Men and Positive Health cohorts: a comparison of trends in the health and sexual behaviour of HIV-negative and HIV-positive gay men, 2002-2005 Sydney University of New South Wales, National Centre in HIV Social Research.
35. National Centre in HIV Research (2011) HIV/AIDS, hepatitis and sexually transmissible infections in Australia: annual report of trends in behaviour 2011 Sydney University of New South Wales.
36. Falster K, Gelgor L, Shaik A, Zablotska I, Prestage G, et al. (2008) Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment. Sex Health 5: 141-154.
37. The Kirby Institute (2011) September Australian HIV Observational Database: annual report Sydney University of New South Wales.
38. Law MG, Woolley I, Templeton DJ, Roth N, Chuah J, et al. (2011) Trends in detectable viral load by calendar year in the Australian HIV observational database. J Int AIDS Soc 14: 10.
39. Mallitt KA, Wilson DP, McDonald A, Wand H, (2011) HIV incidence trends vary between jurisdictions in Australia: an extended back-projection analysis of men who have sex with men. Sex Health 9: 138-143.
40. Grulich AE, Kaldor JM, (2008) Trends in HIV incidence in homosexual men in developed countries. Sex Health 5: 113-118.
41. Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, et al. (2009) Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol 19: 423-431.
42. Morris SR, Little SJ, (2011) MSM: resurgent epidemics. Curr Opin HIV AIDS 6: 326-332.
43. Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, et al. (2008) A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 22: 1071-1077.
44. Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, et al. (2011) Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 25: 493-501.
45. European Centre for Disease Prevention and Control, World Health Organization Regional Office for Europe (2011) HIV/AIDS surveillance in Europe: 2010 Stockholm European Centre for Disease Prevention and Control Available: http://ecdc.europa.eu/en/publications/Publications/101129_SUR_HIV_2009.pdf. Accessed 3 May 2012.
46. Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou A, et al. (2011) HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill 16. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19962. Accessed 3 May 2012.
47. European Monitoring Centre for Drugs and Drug Addiction (2011) Annual report 2011: the state of the drugs problem in Europe Lisbon European Monitoring Centre for Drugs and Drug Addiction Available: http://www.emcdda.europa.eu/attachements.cfm/att_143743_EN_EMCDDA_AR2011_EN.pdf. Accessed 3 May 2012.
48. Zablotska IB, Crawford J, Imrie J, Prestage G, Jin F, et al. (2009) Increases in unprotected anal intercourse with serodiscordant casual partners among HIV-negative gay men in Sydney. AIDS Behav 13: 638-644.
49. Fleming DT, Wasserheit JN, (1999) From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75: 3-17.
50. Galvin SR, Cohen MS, (2004) The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2: 33-42.
51. Fisher M, Pao D, Brown AE, Sudarshi D, Gill ON, et al. (2010) Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 24: 1739-1747.
52. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, et al. (2004) Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18: 81-88.
53. Jin F, Jansson J, Law M, Prestage GP, Zablotska I, et al. (2010) Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 24: 907-913.
54. Kelley CF, Haaland RE, Patel P, Evans-Strickfaden T, Farshy C, et al. (2011) HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum. J Infect Dis 204: 761-767.
55. Wilson DP, (2010) Evidence is still required for treatment as prevention for riskier routes of HIV transmission. AIDS 24: 2891-2893.
56. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ, (2011) The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52: 793-800.
57. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM, (2008) Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 372: 314-320.
58. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, et al. (2006) Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 296: 827-843.
59. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
60. Hayes RJ, White RG, (2011) Role of acute infection in HIV transmission. Lancet 378: 1913-1914 author reply 1914-1915.
61. Williams BG, Granich R, Dye C, (2011) Role of acute infection in HIV transmission. Lancet 378: 1913 author reply 1914-1915.
62. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, et al. (2011) The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 378: 256-268.
63. Miller WC, Rosenberg NE, Rutstein SE, Powers KA, (2010) Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS 5: 277-282.
64. Johnson LF, Hallett TB, Rehle TM, Dorrington RE, (2012) The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface E-pub ahead of print. doi:10.1098/rsif.2011.0826.
65. Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, et al. (2011) Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis 11: 516-524.
66. Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, et al. (2009) Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med 151: 241-251 W-252.
67. Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, et al. (2008) Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV Med 9: 535-543.
68. Kaiser Family Foundation (2011) International AIDS assistance from donor governments: commitments & disbursements, 2002-2010. Available: http://facts.kff.org/chart.aspx?ch=946. Accessed 3 May 2012.
69. Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, et al. (2001) The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med 344: 824-831.
70. Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, et al. (2006) Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med 3: e4 doi:10.1371/journal.pmed.0030004.